pharma news

News

CRISPR biotech Intellia plummets as trial paused for safety

Intellia lost 45% of its value today as phase 3 trials of one of its priority drug programmes were halted due to a patient being hospitalised.

News

Three Chinese label boxes of Innovent's mazdutide

Pressure rises on Novo as Innovent drug tops Ozempic

Innovent's dual glucagon and GLP-1 agonist mazdutide outperforms Novo Nordisk's Ozempic in overweight people with diabetes.

News

Novartis makes $12bn wager on RNA drugs with Avidity buy

Novartis is poised to make one of its largest takeover deals in its history after agreeing to buy RNA specialist Avidity Biosciences for $12bn.

News

Chugai buys 'Asia lag' firm Renalys for $98m upfront

Chugai Pharma has reached a deal to buy Renalys Pharma, a company set up to bring therapies developed elsewhere to markets in Asia.

News

Black and white image of a man putting his finger to his lips to shush

AZ, Organon fall foul of UK's code on pharma promotion

AstraZeneca and Organon have breached the UK pharma industry's code of practice with promotions for an asthma drug and a contraceptive implant.

News

A male HCP discusses treatment with an older male patient

Bayer's prostate cancer drug Nubeqa cleared for NHS use

Thousands of men living with incurable prostate cancer will be able to access an easier-to-tolerate treatment from Bayer, thanks to new NICE guidance.

CRISPR biotech Intellia plummets as trial paused for safety

Pressure rises on Novo as Innovent drug tops Ozempic

Novartis makes $12bn wager on RNA drugs with Avidity buy

Chugai buys 'Asia lag' firm Renalys for $98m upfront

AZ, Organon fall foul of UK's code on pharma promotion

Bayer's prostate cancer drug Nubeqa cleared for NHS use

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks